Abstract: The disclosure relates to dosage forms which include one or more cohesion agents in amounts effective to reduce the likelihood and ease of extraction of an opioid agonist therefrom. The dosage forms exhibit improved resistance to abuse and lesser likelihood of accidental overdosing than similar dosage forms lacking a cohesion agent. Dosage forms including a lipid or waxy component, a cellulose-based release inhibitor, a thixotrope, one or more cohesion agents, and at least one sequestered opioid antagonist. The dosage forms capable of inhibiting or reducing extraction, abuse, or overdose involving the opioid agonist over a broad range of temperatures are disclosed. The dosage forms also deter extraction of the opioid therefrom.

Abstract: The disclosure relates to dosage forms which include one or more cohesion agents in amounts effective to reduce the likelihood and ease of extraction of an opioid agonist therefrom. The dosage forms exhibit improved resistance to abuse and lesser likelihood of accidental overdosing than similar dosage forms lacking a cohesion agent. Dosage forms including multiple cohesion agents capable of inhibiting or reducing extraction, abuse, or overdose over a broad range of temperatures are disclosed.

Abstract: A touch sensitive lighting device and method of controlling thereof. Particularly, the application provides a touch sensitive lighting device which is characterized in having a touch sensitive contact point for operating a lighting source of the touch sensitive lighting device with a single finger of a human being. More particularly, the touch sensitive lighting device comprising of a housing for the touch sensitive lighting device; the lighting source of the touch sensitive lighting device for illumination; a power source for providing power to the lighting source for the touch sensitive lighting device for illumination; the touch sensitive contact point for controlling the lighting source of the touch sensitive lighting device; a circuit board includes circuitry for controlling the lighting source and the power source of the touch sensitive lighting device; and a magnifier lens.

Abstract: The present invention discloses a hand luggage reminder comprising a mainbody (1) operationally connected with a first and a second electric switch boxes (21, 22), a small permanent magnetic rod set (33), and a strong permanent magnet (43); and the mainbody further comprises a main electric switch box (5) operationally connected with a battery box (11), a sound generator box (12), and a permanent magnetic push-to-break switch (16) for easy controlling the sound for reminding a passenger on a vehicle to take out personal belongings while leaving the vehicle. After depressing a button (161) of the push-to-break switch (16) to stop the reminding sound, it needs no another button pressing to restore the reminding function because the reminder cannot be switched off by pressing the button (161). Closing the car door can also stop the reminding sound. The present invention is waterproof, low in cost, easy in installation and operation.

Abstract: The present invention discloses a hand luggage reminder comprising a mainbody (1) operationally connected with a first and a second electric switch boxes (21, 22), a small permanent magnetic rod set (33), and a strong permanent magnet (43); and the mainbody further comprises a main electric switch box (5) operationally connected with a battery box (11), a sound generator box (12), and a permanent magnetic push-to-break switch (16) for controlling and switching the sound generator box for easy generation and termination of a reminding sound for reminding a passenger on a vehicle to take out personal belongings while leaving the vehicle. The present invention is waterproof, low in cost, easy in installation and operation.

Abstract: We provide a pharmaceutical dosage form including an opioid antagonist surrounded by a controlled release matrix and an opioid agonist in a surrounding matrix.

Abstract: We provide a pharmaceutical dosage form including an opioid antagonist surrounded by a controlled release matrix and an opioid agonist in a surrounding matrix.

Abstract: We provide a pharmaceutical dosage form including an opioid antagonist surrounded by a controlled release matrix and an opioid agonist in a surrounding matrix.

Abstract: We provide a pharmaceutical dosage form including an opioid antagonist surrounded by a controlled release matrix and an opioid agonist in a surrounding matrix.